News & Media

News

July 26, 2022

n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research 

June 20, 2022

n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients

June 14, 2022

n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients 

May 25, 2022

n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families 

May 3, 2022

n-Lorem Foundation and Columbia University Establish Silence ALS Initiative 

April 26, 2022

n-Lorem Foundation Welcomes Amy McCooe to its Board of Directors 

April 21, 2022

n-Lorem and The Wolverine Foundation Collaborate to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients 

March 21, 2022

The Conrad Prebys Foundation to Support the Discovery and Development of Personalized ASO Medicines for Nano-rare Patients

March 18, 2022

San Diego Biotech Nonprofit Providing Hope for Patients With Ultra-Rare Diseases – NBC 7 San Diego

March 16, 2022

La Jolla Labs and n-Lorem Foundation Partner to Discover Personalized ASO Medicines for Nano-rare Patients

March 9, 2022

Second Anniversary for n-Lorem Foundation Marks Extraordinary Progress Toward Treating Nano-Rare Patients

February 23, 2022

Parexel and n-Lorem Foundation Partner to Support Development of New Investigational Therapies for Nano-rare Patients

February 8, 2022

n-Lorem Foundation Partners with Cytiva to Bring Individualized ASO Medicines to Patients with Nano-rare Diseases

February 2, 2022

n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare Diseases

January 27, 2022

n-Lorem Foundation Receives $1 million Donation from Alexion to Develop and Provide Free Individualized Medicines to Nano-rare Patients

January 18, 2022

n-Lorem Foundation Partners with Alnylam to Expand Technology Access to RNAi Therapeutics for Patients with Nano-rare Diseases

January 13, 2022

n-Lorem Foundation Announces New Publication in Trends in Molecular Medicine

January 6, 2022

n-Lorem Foundation Notes Latest in Guidance From FDA on Developing ASO Drug Products for Patients With Nano-rare Diseases

January 4, 2022

John Maraganore Joins the n-Lorem Foundation Team as Chair of Its Advisory Council

December 14, 2021

n-Lorem Foundation Welcomes New Members, Jason Wood and Gene Yeo, to its Board of Directors

August 17, 2021

n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer

June 16, 2021

n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases

May 26, 2021

n-Lorem Foundation Welcomes Frank J. Sasinowski to its Board of Directors

May 3, 2021

n-Lorem Foundation Applauds FDA’s Important and Highly Constructive Guidance for Individualized ASO Treatments for Patients with Ultra-Rare Conditions

April 13, 2021

n-Lorem Foundation, ChemGenes Announce Collaboration to Support Manufacturing of Individualized Treatments for Patients with Ultra-Rare Diseases

April 6, 2021

n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases

March 12, 2021

Introducing n-Lorem Foundation – Creating a better future for ultra-rare, one patient at a time

January 26, 2021

n-Lorem Foundation Celebrates One-Year Anniversary as First and Only Organization to Offer Free, Personalized Treatment to Ultra-Rare Disease Patients

December 10, 2020

n-Lorem Foundation Receives $500,000 Donation to Develop Individualized Treatments for Patients with Ultra-Rare Diseases

July 29, 2020

How you can help provide experimental ASO treatments to patients with ultra-ultra-rare diseases.

June 12, 2020

Stan Crooke introduced n-Lorem Foundation at BIO Digital (June 8-12, 2020)

April 14, 2020

n-Lorem Foundation receives $500,000 donation for providing experimental antisense medicines to treat patients with ultra-rare diseases

March 19, 2020

Korea Institute of Toxicology joins growing list of global partners supporting n-Lorem’s efforts to deliver treatments for patients with ultra-rare diseases

March 12, 2020

n-Lorem Foundation receives additional support for providing “n of 1” experimental antisense medicines to treat patients with ultra-rare diseases

January 8, 2020

n-Lorem Foundation established to charitably provide antisense medicines to treat patients with ultra-rare diseases


Media

  • Logos
  • n-Lorem Brochure
  • Dr. Crooke's Bio & Photo